siRNA-mediated suppression of synuclein γ inhibits MDA-MB-231 cell migration and proliferation by downregulating the phosphorylation of AKT and ERK

Journal of Breast Cancer

Volumn 17, Issue 3, 2014, Pages 200-206

  He, Jingsong ^a   Xie, Ni ^a   Yang, Jianbo ^b   Guan, Hong ^a   Chen, Weicai ^a   Wu, Huisheng ^a   Yuan, Zishan ^a   Wang, Kun ^a   Li, Guojin ^a   Sun, Jie ^a   Yu, Limin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Breast neoplasms; Extracellular signal regulated MAP kinases; Human SNCG protein; Proto oncogene proteins c akt; Small interfering RNA

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; FLUORESCEIN ISOTHIOCYANATE; GAMMA SYNUCLEIN; LIPOCORTIN 5; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROPIDIUM IODIDE; PROTEIN KINASE B; SMALL INTERFERING RNA;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MDA MB 231 CELL LINE; MIGRATION INHIBITION; MRNA EXPRESSION ASSAY; MTT ASSAY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; S PHASE CELL CYCLE CHECKPOINT; WESTERN BLOTTING;

EID: 84923324107     PISSN: 17386756     EISSN: 20929900     Source Type: Journal    
DOI: 10.4048/jbc.2014.17.3.200     Document Type: Article

References (25)

1. Smolarek AK, Suh N. Chemopreventive activity of vitamin E in breast cancer: a focus on γ-and δ-tocopherol. Nutrients 2011;3:962-86.
2. Clayton DF, George JM. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 1998;21:249-54.
3. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 1997;276:2045-7.
4. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997;388:839-40.
5. Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, et al. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 1997;57:759-64.
6. Jia T, Liu YE, Liu J, Shi YE. Stimulation of breast cancer invasion and metastasis by synuclein gamma. Cancer Res 1999;59:742-7.
7. Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ, Godwin AK. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 2000; 88:2154-63.
8. Wu K, Weng Z, Tao Q, Lin G, Wu X, Qian H, et al. Stage-specific expression of breast cancer-specific gene gamma-synuclein. Cancer Epidemiol Biomarkers Prev 2003;12:920-5.
9. Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C, et al. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 2005;65:7635-43.
10. Guo J, Shou C, Meng L, Jiang B, Dong B, Yao L, et al. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer. Int J Cancer 2007;121:1296-305.
11. Jiang Y, Liu YE, Goldberg ID, Shi YE. Gamma synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor alpha signaling and mammary tumorigenesis. Cancer Res 2004;64:4539-46.
12. Zhou Y, Inaba S, Liu J. Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment. Int J Oncol 2006;29:289-95.
13. Pan ZZ, Bruening W, Giasson BI, Lee VM, Godwin AK. Gamma-synuclein promotes cancer cell survival and inhibits stress and chemotherapy drug-induced apoptosis by modulating MAPK pathways. J Biol Chem 2002;277:35050-60.
14. Singh VK, Zhou Y, Marsh JA, Uversky VN, Forman-Kay JD, Liu J, et al. Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs. Cancer Res 2007; 67:626-33.
15. Lavedan C, Leroy E, Dehejia A, Buchholtz S, Dutra A, Nussbaum RL, et al. Identification, localization and characterization of the human gamma-synuclein gene. Hum Genet 1998;103:106-12.
16. Zhao W, Liu H, Liu W, Wu Y, Chen W, Jiang B, et al. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration. Int J Oncol 2006;28:1081-8.
17. Zhou CQ, Liu S, Xue LY, Wang YH, Zhu HX, Lu N, et al. Down-regulation of gamma-synuclein in human esophageal squamous cell carcinoma. World J Gastroenterol 2003;9:1900-3.
18. Liu C, Guo J, Qu L, Bing D, Meng L, Wu J, et al. Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients. Cancer Lett 2008;269:148-58.
19. Li Z, Sclabas GM, Peng B, Hess KR, Abbruzzese JL, Evans DB, et al. Overexpression of synuclein-gamma in pancreatic adenocarcinoma. Cancer 2004;101:58-65.
20. Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, Yoshimura K, et al. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Sci 2004;95:955-61.
21. Fung KM, Rorke LB, Giasson B, Lee VM, Trojanowski JQ. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas. Acta Neuropathol 2003;106:167-75.
22. Jiang Y, Liu YE, Lu A, Gupta A, Goldberg ID, Liu J, et al. Stimulation of estrogen receptor signaling by gamma synuclein. Cancer Res 2003; 63:3899-903.
23. Gupta A, Inaba S, Wong OK, Fang G, Liu J. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1. Oncogene 2003; 22:7593-9.
24. Inaba S, Li C, Shi YE, Song DQ, Jiang JD, Liu J. Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treat 2005;94:25-35.
25. Zhang W, Ohnishi K, Shigeno K, Fujisawa S, Naito K, Nakamura S, et al. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia 1998;12:1383-91.